CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma

Differential PAX3 functions in normal skin melanocytes and melanoma cells

(2011) Sandra Medic et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Combination of targeted therapy and immunotherapy in melanoma

(2011) Christian U. Blank et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells

(2011) Ling Yu et al.   IMMUNOLOGIC RESEARCH

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma

(2011) Jian Wang et al.   PLoS One

Eradication of melanomas by targeted elimination of a minor subset of tumor cells

(2011) P. Schmidt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transmembrane Signaling Proteoglycans

(2010) John R. Couchman   Annual Review of Cell and Developmental Biology

NG2 cells: Properties, progeny and origin

(2010) Jacqueline Trotter et al.   BRAIN RESEARCH REVIEWS

Activation of the Integrin Effector Kinase Focal Adhesion Kinase in Cancer Cells Is Regulated by Crosstalk between Protein Kinase C  and the PDZ Adapter Protein mda-9/Syntenin

(2010) C. Hwangbo et al.   CANCER RESEARCH

CSPG4 in Cancer: Multiple Roles

(2010) X. Wang et al.   CURRENT MOLECULAR MEDICINE

Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse

(2010) Feng-Ju Huang et al.   DEVELOPMENTAL BIOLOGY

CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

(2010) Xinhui Wang et al.   JNCI-Journal of the National Cancer Institute

Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-κB

(2010) H Boukerche et al.   ONCOGENE

A role for the NG2 proteoglycan in glioma progression

(2010) William B. Stallcup et al.   Cell Adhesion & Migration

Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition

(2009) J. Yang et al.   CANCER RESEARCH

Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification

(2009) Ilknur Kozanoglu et al.   CYTOTHERAPY

Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells

(2009) Michael P. O'Connell et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature

(2008) P. C. Maciag et al.   CANCER RESEARCH

Hyaluronan and hyaluronidase in genitourinary tumors

(2008) Melanie et al.   Frontiers in Bioscience-Landmark

Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+T cells in melanoma patients

(2008) Cornelia Erfurt et al.   INTERNATIONAL JOURNAL OF CANCER

Interaction of Syntenin-1 and the NG2 Proteoglycan in Migratory Oligodendrocyte Precursor Cells

(2008) Nivedita Chatterjee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling

(2008) M Chekenya et al.   ONCOGENE

mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src

(2008) H. Boukerche et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells

(2008) Bryan P. Toole et al.   SEMINARS IN CANCER BIOLOGY